(Q68925812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

[Studies on the constituents of Rhododendron metternichii Sieb. et Zucc. var. hondoense Nakai (author's transl)] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

Rhododendron japonoheptamerum

28 September 2019

main subject

1 reference

Rhododendron metternichii

1 reference

(1R,3aR,5aR,5bR,7aR,9S,11aR,11bS,13aR,13bS)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol

1 reference

1 reference

(1R,3aR,5aS,5bR,7aS,9S,11aR,11bS,13aS,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

1 reference

1 reference

Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-

1 reference

(1R,2S,4aS,6aR,6aS,6bS,8aS,10S,12aR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid

1 reference

[(1R,3S,4S,6R,8S,9R,10S,13S,14S,16R)-3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyl-16-tetracyclo[11.2.1.01,10.04,8]hexadecanyl] acetate

1 reference

Lup-20(29)-en-28-oic acid, 3beta-hydroxy-

1 reference

(1R,3S,4S,6R,8S,9R,10S,13S,14S,16R)-5,5,9,14-tetramethyltetracyclo[11.2.1.01,10.04,8]hexadecane-3,4,6,9,14,16-hexol

1 reference

1 reference

H Oue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

M Onishi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

H Meguri

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1974

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/yakushi1947/94/6/94_6_756/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/yakushi1947.94.6_756?email=unpaywall_01@example.com

published in

Journal of the Pharmaceutical Society of Japan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

756-758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/yakushi1947.94.6_756?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

Identifiers

DOI

10.1248/YAKUSHI1947.94.6_756

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4472637%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference